How Do We Escalate High-Dollar Claims Stuck in Payer Review?

What Actually Moves a Six-Figure Claim Out of Payer Review

The goal is simple: the largest claims worked first, worked often, and escalated on a real timeline, so a pended six-figure claim does not sit for weeks financing someone else’s cash flow. Here is what does that, move by move.

1. Tier Your Follow-Up by Claim Value, Not a Flat Cadence

The first move is to stop working a forty-thousand-dollar claim on the same schedule as a ninety-dollar visit. Sort the AR by dollar value and put the high-dollar claims in their own tier with a tight, aggressive follow-up cadence: worked within days of pending, then again on a short clock, not a 45-day round-robin. Most practices never do this because the queue is built on claim age, not claim value, so the biggest exposures get the same touch as the smallest. Value-tiering is the change that decides which claims get attention while there is still margin to protect.

2. Resolve the Review on the Payer’s Actual Terms

A claim in review is usually waiting on something specific: a chart note, a records request, a medical-necessity element, or a coordination-of-benefits answer. The mistake is guessing. Before the follow-up call, the specialist confirms exactly what the payer flagged, assembles precisely those records, and sends them to the entity and address that can actually clear the pend, not a general fax that vanishes. Payers increasingly require a chart note or records request before releasing payment on high-dollar claims, so the fastest path out of review is giving them the exact thing they asked for the first time.

3. Escalate Through Named Contacts and a Real Timeline

The general status line is where high-dollar claims go to wait. Escalation means a named provider-relations or claims-escalation contact, a documented reference number, and a defined timeline the payer commits to on the record. When a six-figure claim has been pended past a reasonable window, that is not a status call, it is an escalation: supervisor, escalation unit, and if the contract or state prompt-pay rules are in play, a written demand that cites them. A claim that has a name attached and a clock running moves; a claim sitting in the general queue does not.

4. Track the Carrying Cost So the Delay Becomes a Number

A pended high-dollar claim is not free to wait on, and leadership cannot act on what it cannot see. Track every claim in review by value, days pended, and the cost of the drug or service already delivered, so the carrying cost of the delay is a visible number, not a vague frustration. That number does two things: it tells you which claims to escalate hardest, and it gives you the evidence to push the payer, and if needed a regulator, on a pattern of stalling. What gets measured gets escalated; what sits in a general AR bucket gets forgotten.

5. Hand High-Dollar Escalation to a Dedicated Team

Practices that stop letting six-figure claims finance the payer do it by handing value-tiered follow-up to a dedicated team: remote specialists who tier the AR, resolve the review on the payer’s terms, escalate through named contacts, and track the carrying cost, live in 1 to 2 weeks. The billing lead stops babysitting the biggest claims between everything else, a trained backup covers every gap, and the review queue stops being where margin quietly disappears. Below is what it sounds like when nobody owns this yet, in billing teams’ own words.

Why This Keeps Happening

If the fix is that clear, why do high-dollar claims keep drifting in review? Because the follow-up queue is built on claim age, not claim value, and a pended-not-denied claim generates no denial to work. A forty-thousand-dollar infusion and a ninety-dollar visit both land in the same aging bucket, get the same status touch on the same cadence, and the six-figure exposure gets no more attention than the routine one. There is no reason code, no appeal deadline, nothing that flags it as different, so it drifts. Reworking the queue so the largest claims get worked first and worked often is exactly what disciplined revenue cycle management is built to do.

The delay is not always innocent, either. A Becker’s analysis of roughly 80 million transactions found payers increasingly stalling payment on reviewed and high-dollar claims, and industry reporting shows several payers now requiring a chart note or records request before releasing payment, a step most common on high-dollar drug and infusion claims. What the payer deems sufficient is driven by proprietary rules and clinical guidelines that vary by plan, so a claim can sit in review not because anything is wrong with it but because the review itself is the delay. When that claim lands in a busy AR queue with no escalation path, the payer’s slow clock becomes the practice’s carrying cost, which is exactly the gap an AI medical billing workflow with human oversight is built to close.

And the cost of that delay is not abstract for a practice carrying drug costs. When you have already paid for a six-figure infusion, every week the claim sits in review is your capital financing the payer’s cash flow, not theirs. The lost time value is real, the strain on the practice’s own cash position is real, and because the claim is pended rather than denied, none of it shows up in the denial metrics leadership watches. It hides in the AR aging as a slow claim, when it is actually the most expensive claim on the books quietly costing the practice money it already spent.

Most groups have already tried the obvious fixes before they talk to anyone. Each one fails the same way: the work lands back on the practice. The pattern, in one table:

The Solution

So what does “someone whose whole job it is” look like on a six-figure claim in review? The specialist tiers the AR by value the day the claim pends, so the largest claims go into an aggressive follow-up track instead of the flat cadence. Then they resolve the review on the payer’s actual terms: confirm precisely what was flagged, assemble exactly those records, and send them to the entity that can clear the pend rather than a general fax that disappears. Most high-dollar delays are a value-prioritization and records-routing problem, and that is exactly what dedicated accounts receivable follow-up is built to solve, before the carrying cost eats the margin.

When a high-dollar claim sits past a reasonable window, the specialist escalates instead of accepting another status call. They work a named provider-relations or claims-escalation contact, log a reference number, and hold the payer to a committed timeline, citing the contract or prompt-pay rules in writing when the delay warrants it. And they track the carrying cost of every parked claim by value and days pended, so the delay stops being a vague frustration and becomes a number leadership can act on and, if the pattern is a payer tactic, push back against.

Behind all of it, AI drafts the first pass and a credentialed human verifies. The workflow tiers the AR, flags what each pended claim is waiting on, and tracks the days and dollars in review; a person confirms the records are right, owns the escalation call, and makes the judgment on when to push a payer. Every security control that protects the clinical and financial data moving through that process is documented and auditable, and the whole approach is described on our HIPAA and security page, because moving chart notes and claim data through an escalation workflow is only safe when the controls are real.

Who Actually Does This Work

Fair question: why would an outsourced team move your stuck claims better than your own biller? Because tiering AR by value, reading what a payer actually flagged, and running a real escalation is their entire day, not the thing they squeeze between posting the routine claims. The people working your high-dollar AR are credentialed medical professionals: overseas-trained physicians, US-licensed nurses and pharmacists, and PharmDs, all trained in US revenue cycle and payer-escalation workflows. They know a pended claim is not a slow claim, they know how to assemble exactly the records a medical-necessity review wants, and they know how to escalate past the general status line to a name and a timeline. That is not a task you hand to whoever is free; it is a specialty.

We are not a call center. We are a clinical operations partner, a healthcare BPO built on dedicated virtual staff: 500+ credentialed professionals, 24/7 coverage, and the AI-first-pass plus human-verify workflow you just read about behind every one of them. A typical practice is live in 1 to 2 weeks, at up to 70% below the cost of hiring locally, and no one on our side goes out without a trained backup already inside your workflow, so a six-figure claim never sits in review because the one person who chases it is on vacation.

And the security piece your compliance officer will ask about: we are audited to SOC 2 Type II with zero exceptions and certified for ISO/IEC 27001:2022, HIPAA, and GDPR, with zero breaches in eight years. Every workstation runs inside a secure enclave on US-based servers, with screen captures and downloads blocked by policy, so PHI never sits on someone’s home laptop. Every client account carries a $5M E&O and cyber liability policy and a BAA signed before any work starts; the full detail lives in our HIPAA and security posture.

Put the routine and the people together, and a specific list of things simply stops happening.

How We Permanently Fix the Process

A person alone is not the fix, and neither is a bot alone. The fix is a documented value-tiered follow-up workflow: which dollar thresholds trip the aggressive cadence, what each payer typically flags on a high-dollar review, the exact records and routing that clear a pend fastest, the named escalation contacts per payer, and how the carrying cost is tracked and reported, all written down and worked the same way every time. Before we take a single claim for a new practice, we chart your high-dollar AR by payer and days pended so we can see where margin is actually being lost, and we build the workflow against that, not against a generic template.

From there the workflow becomes a living playbook rather than tribal knowledge in one biller’s head. It records each payer’s review behavior, what a medical-necessity or records pend really requires, the escalation contacts and reference-number trail, and the reporting that puts the carrying cost in front of leadership. It is written down, kept current as payers change tactics, and owned by the team. When your specialist is out, a trained backup works the same playbook the same way, so a six-figure claim never sits because the one person who escalates it is off that week.

That is the difference between chasing this month’s stuck claims and fixing the process for good, and it is what a dedicated revenue cycle management partner actually buys you. A biller leaving used to mean the biggest claims drifted back into the general queue and the carrying cost climbed unseen. Under this model the workflow keeps running, the playbook stays, the backup steps in, and a high-dollar claim in review stops being the thing that quietly finances the payer.

The Whole Thing in Four Sentences

High-dollar claims get stuck in payer review because follow-up is uniform: a six-figure infusion claim gets the same 45-day touch as a routine visit, and a pended-not-denied status trips no alarm and generates nothing to appeal. Working them on the flat cadence, sending the whole chart on a records request, and calling the general status line all fail the same way. The fix is to tier follow-up by claim value, resolve the review on the payer’s actual terms, escalate through named contacts on a real timeline, and track the carrying cost so the delay becomes a number leadership can act on. An independent multi-provider specialty group runs exactly this model with us today, names withheld, no patient data shown.

If you want to check us out before talking to anyone: our security posture is independently auditable, we are an MGMA 2026 Corporate Member, and 800+ providers run back office work with us.

Ready to stop financing the payer’s delay? Try us risk free: two weeks, your real high-dollar AR, dedicated specialists tiering and escalating the biggest claims, and if it does not earn the handoff, you walk away. From here down is the sales part, and it is short: here is exactly what it costs.

Written By

Dan Nandan

Founder and CEO, Staffingly, Inc. · Piscataway, NJ

Dan Nandan has spent 25+ years in IT consulting and healthcare BPO, was among the first in the US to build an RPO/BPO delivery network in India, and has been featured in Computerworld. He runs the operations and the dedicated virtual teams behind the workflows on this page; the team-voice answers above come from the remote specialists who work them every day.

Connect on LinkedIn

Where the Claims on This Page Come From